• 

  May 7, 2022

  Understanding Your Breast Pathology Report

  Dr. C H Weaver MD

• 

  April 20, 2022

  BSO-Surgically Induced Menopause

  Dr. C H Weaver MD

• 

  March 5, 2021

  Overview of Prostate Cancer

  Dr. C H Weaver MD

• 

  March 4, 2021

  Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer

  Dr. C H Weaver MD

• 

  January 23, 2021

  Precision Cancer Medicines for Prostate Cancer

  Dr. C H Weaver MD

• 

  January 16, 2021

  More Than 12% of Men with Prostate Cancer Carry a Genetic Mutation

  Dr. C H Weaver MD

• 

  September 30, 2020

  PARP Inhibitors – Effective in Men with BRCA-Mutant Prostate Cancer

  Dr. C H Weaver MD

• 

  August 22, 2020

  Treatment & Management of Ovarian Cancer

  Dr. C H Weaver MD

• 

  August 18, 2020

  Treatment of Early Stage TNBC

  Dr. C H Weaver MD

• 

  August 9, 2020

  Prophylactic Mastectomy in Women with Genetic Risk of Breast Cancer

  Dr. C H Weaver MD

• 

  October 2, 2019

  Zejula (Niraparib) Improves Progression-Free Survival in Ovarian Cancer

  Dr. C H Weaver MD

• 

  October 1, 2018

  Treatment of Stage III Ovarian Cancer

  Dr. C H Weaver MD